PureTech Health noted that its Founded Entity, Karuna Therapeutics announced the submission of a new drug application, or NDA, to the FDA for KarXT for the treatment of schizophrenia.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on PRTC: